Drugs / Shensong Yangxin capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01612260 | Sep 2012 → Aug 2013 | cardiac rhythm disease, systolic heart failure | Cong-xin Huang | Unknown | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shensong Yangxin capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01612260 ↗ |
| Known as | SSYX | “Chinese traditional medicine Shensong Yangxin capsules (SSYX)” PMID 28685712 ↗ Jul 2017 |
| Modality | Traditional medicine (herbal / TCM) | “Chinese traditional medicine Shensong Yangxin capsules (SSYX)” PMID 28685712 ↗ Jul 2017 |
| Route | Oral | “ShenSongYangXin Capsule 4 granules t.i.d. po for 12weeks” NCT01612260 ↗ |